Today, Florida Governor Ron DeSantis (R) announced the Agency for Health Care Administration has officially submitted the Section 804 Importation Proposal to the U.S. Department of Health and Human Services for Florida’s Canadian Prescription Drug Importation Program.
In a statement, the Florida Governor informed that “for far too long, Floridians have been paying. Exorbitant prices for prescription drugs,” noting that “today, we take another step towards lowering those prices by submitting a proposal to the U.S. Department of Health and Human Services for a first of its kind Canadian Prescription Drug Importation Program.” Moreover, Governor DeSantis assured that his “administration will continue to work collaboratively in an effort to bring affordable prescription drugs to all Floridians.”
It was in 2019 that Governor DeSantis and the Florida Legislature initiated this program, which aimed to lower prescription drug prices that are integral to maintaining the quality and health of Floridians.
Echoing in DeSantis’ remarks, Shevaun Harris, the Acting Secretary of the AHCA, added that the “proposal submission is the result of bold leadership from Governor Ron DeSantis and his continued efforts to make prescription drug prices affordable for Floridians,” noting that she understands “that this crucial step Florida is taking towards effective change will be a catalyst for other states around the nation.”
In turn, Harris concluded that she “will continue to work hard to bring down these prices that have burdened too many Floridians.”
The AHCA is expected to contract with a vendor that will manage and oversee all aspects of the program to ensure that Canadian suppliers and eligible importers are complying with the federal and state law requirements.